SALT LAKE CITY, July 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today launched Valence Labs at ...
MONTREAL & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Valence Discovery (“Valence”), a leader in AI-first design of novel chemistry against previously intractable biology, announced today that it has closed ...
Led by Microsoft’s M12 venture fund, Valence’s Series A round accelerates the company’s ability to help customers secure their SaaS mesh from risk created by democratized end user adoption, ...
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic ...